SC 13G Filing

Company

C4 Therapeutics, Inc.

Filed

July 25, 2023

Accession Number

0001273087-23-000125

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →